氯氮平停药引起恶性卡塔尼亚的电休克治疗——病例系列

Sean Allan , Humaira Shoaib , Andrew Spitzberg , Joanna Drucker , Xavier Jimenez , Georgios Petrides , Sohag Sanghani
{"title":"氯氮平停药引起恶性卡塔尼亚的电休克治疗——病例系列","authors":"Sean Allan ,&nbsp;Humaira Shoaib ,&nbsp;Andrew Spitzberg ,&nbsp;Joanna Drucker ,&nbsp;Xavier Jimenez ,&nbsp;Georgios Petrides ,&nbsp;Sohag Sanghani","doi":"10.1016/j.psycr.2023.100175","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Clozapine, a pharmacologically complex second-generation antipsychotic, is the standard of care for treatment resistant schizophrenia. Abrupt cessation of clozapine can lead to severe medical complications like cholinergic rebound, psychiatric decompensation, and the development or reappearance of catatonia. Malignant catatonia, an acute and life-threatening form of catatonia with autonomic dysfunction and instability, has been observed to occur secondary to clozapine withdrawal. Malignant catatonia has a significant mortality rate and requires prompt diagnosis and treatment with lorazepam and/or electroconvulsive therapy. There have been few published cases observing malignant catatonia secondary to clozapine withdrawal, and even fewer cases reporting successful treatment with electroconvulsive therapy</p></div><div><h3>Objectives</h3><p>To identify and present new cases of malignant catatonia secondary to clozapine withdrawal that were successfully treated with electroconvulsive therapy.</p></div><div><h3>Methods</h3><p>We present a series of 3 cases (3 case reports) of patients who developed catatonic symptoms with autonomic instability after abruptly discontinuing clozapine.</p></div><div><h3>Results</h3><p>In all three cases, malignant catatonia was diagnosed and initially treated with lorazepam with little effect. With worsening autonomic instability and catatonic symptoms, and minimal improvement with lorazepam, patients were ultimately effectively treated with electroconvulsive therapy.</p></div><div><h3>Conclusion</h3><p>Malignant catatonia should be considered early in patients presenting with catatonic symptoms, abnormal behavior, and autonomic dysfunction in the setting of abrupt clozapine discontinuation. Although the first line treatment for catatonia and malignant catatonia is lorazepam, benzodiazepine medications alone may not be sufficient in cases of clozapine withdrawal. Electroconvulsive therapy has been shown to be an effective treatment in managing malignant catatonia in the setting of clozapine withdrawal.</p></div>","PeriodicalId":74594,"journal":{"name":"Psychiatry research case reports","volume":"2 2","pages":"Article 100175"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Electroconvulsive Therapy For Malignant Catatonia Due To Clozapine Withdrawal—A Case Series\",\"authors\":\"Sean Allan ,&nbsp;Humaira Shoaib ,&nbsp;Andrew Spitzberg ,&nbsp;Joanna Drucker ,&nbsp;Xavier Jimenez ,&nbsp;Georgios Petrides ,&nbsp;Sohag Sanghani\",\"doi\":\"10.1016/j.psycr.2023.100175\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Clozapine, a pharmacologically complex second-generation antipsychotic, is the standard of care for treatment resistant schizophrenia. Abrupt cessation of clozapine can lead to severe medical complications like cholinergic rebound, psychiatric decompensation, and the development or reappearance of catatonia. Malignant catatonia, an acute and life-threatening form of catatonia with autonomic dysfunction and instability, has been observed to occur secondary to clozapine withdrawal. Malignant catatonia has a significant mortality rate and requires prompt diagnosis and treatment with lorazepam and/or electroconvulsive therapy. There have been few published cases observing malignant catatonia secondary to clozapine withdrawal, and even fewer cases reporting successful treatment with electroconvulsive therapy</p></div><div><h3>Objectives</h3><p>To identify and present new cases of malignant catatonia secondary to clozapine withdrawal that were successfully treated with electroconvulsive therapy.</p></div><div><h3>Methods</h3><p>We present a series of 3 cases (3 case reports) of patients who developed catatonic symptoms with autonomic instability after abruptly discontinuing clozapine.</p></div><div><h3>Results</h3><p>In all three cases, malignant catatonia was diagnosed and initially treated with lorazepam with little effect. With worsening autonomic instability and catatonic symptoms, and minimal improvement with lorazepam, patients were ultimately effectively treated with electroconvulsive therapy.</p></div><div><h3>Conclusion</h3><p>Malignant catatonia should be considered early in patients presenting with catatonic symptoms, abnormal behavior, and autonomic dysfunction in the setting of abrupt clozapine discontinuation. Although the first line treatment for catatonia and malignant catatonia is lorazepam, benzodiazepine medications alone may not be sufficient in cases of clozapine withdrawal. Electroconvulsive therapy has been shown to be an effective treatment in managing malignant catatonia in the setting of clozapine withdrawal.</p></div>\",\"PeriodicalId\":74594,\"journal\":{\"name\":\"Psychiatry research case reports\",\"volume\":\"2 2\",\"pages\":\"Article 100175\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatry research case reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2773021223000731\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry research case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773021223000731","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

氯氮平是一种药理学复杂的第二代抗精神病药,是治疗难治性精神分裂症的标准治疗药物。突然停用氯氮平可导致严重的医学并发症,如胆碱能反弹、精神失代偿以及紧张症的发生或再次出现。恶性紧张症是一种急性和危及生命的紧张症,伴有自主神经功能障碍和不稳定,已被观察到继发于氯氮平戒断。恶性紧张症死亡率高,需要及时诊断并使用劳拉西泮和/或电休克治疗。报道氯氮平戒断后继发恶性紧张症的病例很少,电惊厥治疗成功的病例更少目的发现并报道电惊厥治疗氯氮平戒断后继发恶性紧张症的新病例。方法报告3例(3例报告)突然停用氯氮平后出现紧张性症状并伴有自主神经不稳定的患者。结果3例患者均确诊为恶性紧张症,初用劳拉西泮治疗,效果不明显。随着自主神经不稳定和紧张症状的恶化,劳拉西泮的改善甚微,患者最终接受电休克治疗。结论在突然停用氯氮平的情况下,出现紧张症症状、行为异常和自主神经功能障碍的患者应及早诊断为恶性紧张症。虽然对紧张症和恶性紧张症的一线治疗是劳拉西泮,但在氯氮平戒断的情况下,单独使用苯二氮卓类药物可能不够。电休克疗法已被证明是一种有效的治疗恶性紧张症在设置氯氮平戒断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Electroconvulsive Therapy For Malignant Catatonia Due To Clozapine Withdrawal—A Case Series

Background

Clozapine, a pharmacologically complex second-generation antipsychotic, is the standard of care for treatment resistant schizophrenia. Abrupt cessation of clozapine can lead to severe medical complications like cholinergic rebound, psychiatric decompensation, and the development or reappearance of catatonia. Malignant catatonia, an acute and life-threatening form of catatonia with autonomic dysfunction and instability, has been observed to occur secondary to clozapine withdrawal. Malignant catatonia has a significant mortality rate and requires prompt diagnosis and treatment with lorazepam and/or electroconvulsive therapy. There have been few published cases observing malignant catatonia secondary to clozapine withdrawal, and even fewer cases reporting successful treatment with electroconvulsive therapy

Objectives

To identify and present new cases of malignant catatonia secondary to clozapine withdrawal that were successfully treated with electroconvulsive therapy.

Methods

We present a series of 3 cases (3 case reports) of patients who developed catatonic symptoms with autonomic instability after abruptly discontinuing clozapine.

Results

In all three cases, malignant catatonia was diagnosed and initially treated with lorazepam with little effect. With worsening autonomic instability and catatonic symptoms, and minimal improvement with lorazepam, patients were ultimately effectively treated with electroconvulsive therapy.

Conclusion

Malignant catatonia should be considered early in patients presenting with catatonic symptoms, abnormal behavior, and autonomic dysfunction in the setting of abrupt clozapine discontinuation. Although the first line treatment for catatonia and malignant catatonia is lorazepam, benzodiazepine medications alone may not be sufficient in cases of clozapine withdrawal. Electroconvulsive therapy has been shown to be an effective treatment in managing malignant catatonia in the setting of clozapine withdrawal.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Psychiatry research case reports
Psychiatry research case reports Medicine and Dentistry (General)
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信